Embody vs Found: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent researchHow we rank →

Embody and Found are tied at 7.3/10. Found is more affordable at $129/mo vs $149/mo. Choose Embody for people who want the oral tirzepatide gum, or who'll choose t. Choose Found for insured patients who want their glp-1 coverage checked and t.

A side-by-side look at Embody and Found to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for

Embody

#37 of 52
7.3/10

Online weight-loss program that ships compounded GLP-1 medication to your door. Run by Modern Metabolic Medicine, Inc. and prescribed through CareGLP Affiliated P.C.s, their network of licensed doctors. Two pricing plans run side by side: a promo plan starting at $99/mo for semaglutide (or $149/mo for tirzepatide) that jumps after month 1, and 'Embody Flat' at $299/mo that doesn't go up. Their standout: oral tirzepatide gum, for people who don't want to inject.

Visit Embody

Found

#36 of 52
7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found
FeatureEmbodyFound
Our Score7.3/107.3/10
Starting Price$149/mo$129/mo
Medication TypeCompoundedBoth
Insurance AcceptedNoYes
Best ForPeople who want the oral tirzepatide gum, or who'll choose the $299/mo 'Embody Flat' plan at signup for one predictable priceInsured patients who want their GLP-1 coverage checked and their copay minimized
Ranking#37#36
Get startedVisit EmbodyVisit Found

Pros & Cons Compared

Embody

Pros

  • +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
  • +Cheap first month, $99 for semaglutide or $149 for tirzepatide. Among the lowest entry prices in the category.
  • +'Embody Flat' plan is $299/mo flat with no surprise increases, predictable if you pick it from the start.
  • +100% money-back guarantee in writing: if you follow the program and don't see results in 6 months, they say they'll make it right.
  • +Replies to every negative Trustpilot review, usually within 24 hours.

Cons

  • Two plans run side by side and the switchover isn't always clear at signup: the $149 promo month steps up to $299–$399 from month 2 (Embody confirms both plans in its review replies). Pick 'Embody Flat' at signup if you want one predictable number.
  • Trustpilot rating is a polarized 3.3 / 5 across 46 reviews: 41% five-star, 24% one-star. Price is the top complaint theme, most of it tied to the promo-to-flat switchover above.
  • Embody doesn't name which pharmacy makes the medication, just 'multiple USA certified pharmacies.' This is the norm in the category, most major brands (Embody, Henry, Hims, Yucca, Eden) don't publicly name their pharmacy partners; ask support directly if provenance matters to you.
  • No HIPAA disclosure on their site (HIPAA is the federal law protecting your medical info, most telehealth providers publish a statement confirming they follow it).
  • Compounded medications only, no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic available.
  • If you stop treatment and come back, Embody's doctors will likely restart you at the lowest dose (2.5mg). It's their safety policy; raise your dose history at signup, the prescriber makes the final call.

Found

Pros

  • +Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
  • +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
  • +Typical insured copay of ~$30/mo for most members, dramatically lower than cash-pay alternatives
  • +Most members start treatment within one week of completing the health questionnaire

Cons

  • Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying
  • The insurance navigation process adds steps compared to simple cash-pay platforms; the payoff is the ~$30 typical copay
  • Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does

Our Verdict

Embody and Found are closely matched with identical scores of 7.3/10. If budget is your priority, Found starts at $129/mo compared to Embody's $149/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: people who want the oral tirzepatide gum, or who'll choose the $299/mo 'embody flat' plan at signup for one predictable price. Choose Found if you want: insured patients who want their glp-1 coverage checked and their copay minimized.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Embody nor Found feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Try Embody

Starting at $149/mo

Visit Embody

Try Found

Starting at $129/mo

Visit Found

Related comparisons

Other matchups readers comparing Embody or Found tend to look at next.

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Featured Partners

Four affiliate partners we feature, we may earn a commission.

Yucca Health

7.7/10
$146/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

TrimRx

7.8/10
$149/mo·Compounded

SkinnyRx

7.3/10
$199/mo·Compounded

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.